| Medical and Health Sciences | Lifetime | 829 | FI 7 | 99.96 |
| Reproductive Medicine | Lifetime | 14 | FI 1 | 99.89 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 93 | FI 3 | 99.71 |
| Public, Environmental and Occupational Health | Lifetime | 360 | FI 3 | 99.49 |
| Genetics | Lifetime | 374 | FI 5 | 99.14 |
| Endocrine and Autonomic Systems | Lifetime | 965 | FI 2 | 70.20 |
| Reproductive Medicine | 2021-2025 | 178 | FI 2 | 91.82 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 518 | FI 2 | 82.95 |
| Sperm and Testicular Function | Lifetime | 7 | FI 1 | 99.91 |
| Hormonal and reproductive studies | Lifetime | 13 | FI 2 | 99.78 |
| Hypothalamic control of reproductive hormones | Lifetime | 8 | FI 1 | 99.70 |
| Reproductive Biology and Fertility | Lifetime | 40 | FI 1 | 99.73 |
| Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities | Lifetime | 17 | FI 1 | 99.56 |
| Sexual Differentiation and Disorders | Lifetime | 23 | FI 1 | 99.58 |
| Ovarian function and disorders | Lifetime | 38 | FI 1 | 99.71 |
| Estrogen and related hormone effects | Lifetime | 142 | FI 2 | 99.32 |
| Growth Hormone and Insulin-like Growth Factors | Lifetime | 111 | FI 1 | 99.15 |
| Testicular diseases and treatments | Lifetime | 55 | FI 2 | 99.09 |
| Birth, Development, and Health | Lifetime | 580 | FI 13 | 98.37 |
| Ovarian cancer diagnosis and treatment | Lifetime | 579 | FI 6 | 97.70 |
| Animal Genetics and Reproduction | Lifetime | 492 | FI 1 | 96.86 |
| Muscle metabolism and nutrition | Lifetime | 571 | FI 7 | 97.50 |
| Effects and risks of endocrine disrupting chemicals | Lifetime | 520 | FI 7 | 97.32 |
| Reproductive System and Pregnancy | Lifetime | 709 | FI 6 | 96.75 |
| Pharmacological Effects and Assays | Lifetime | 284 | FI 2 | 96.34 |
| Pharmacology and Obesity Treatment | Lifetime | 374 | FI 11 | 95.95 |
| Hormonal and reproductive studies | 2021-2025 | 257 | FI 3 | 89.80 |
| Reproductive Biology and Fertility | 2021-2025 | 985 | FI 6 | 88.98 |
| Hypothalamic control of reproductive hormones | 2021-2025 | 81 | FI 2 | 85.66 |
| Ovarian function and disorders | 2021-2025 | 757 | FI 7 | 85.39 |
| Estrogen and related hormone effects | 2021-2025 | 631 | FI 6 | 76.52 |
| Paraoxonase enzyme and polymorphisms | 2021-2025 | 188 | FI 1 | 36.02 |
